CEFO Bio
Latest round
- Series D
Last raised
- Mar 2023
Total raised
- $9.7M
Investors
- 3
About CEFO Bio
, trading under the name CEFO Bio, operates as a company that conducts research and development of stem cell therapy. The company was co-founded by its CEO, Hyunsook Park. The company is involved in the commercialization of stem cell therapy. CEFO Bio also provides an extensive selection of items and medications associated with stem cells and tissues, including primary and stem cells, cell growth medium, enzymes, and human adipocyte-conditioned media extract. Their products find application in primary cultured cells, cell culture fluid, collagenase, and cell freezing storage boxes, facilitating researchers in their endeavours to advance regenerative medicine using these resources.
Who invested in CEFO Bio
3 investors across 3 rounds
See all investors in CEFO Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CEFO Bio
Who invested in CEFO Bio?
CEFO Bio has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CEFO Bio raised?
CEFO Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did CEFO Bio last raise money?
CEFO Bio's most recent round on record is a Series D, in Mar 2023.
What does CEFO Bio do?
, trading under the name CEFO Bio, operates as a company that conducts research and development of stem cell therapy.
Where is CEFO Bio headquartered?
CEFO Bio is headquartered in Seoul, South Korea.
Which VCs invest in companies like CEFO Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at CEFO Bio's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like CEFO Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.